4//SEC Filing
Sablich Kim 4
Accession 0001140361-23-010160
CIK 0001305253other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:50 PM ET
Size
5.0 KB
Accession
0001140361-23-010160
Insider Transaction Report
Form 4
Sablich Kim
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+28,000→ 28,000 totalExercise: $1.71Exp: 2033-02-28→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001758790
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:50 PM ET
- Size
- 5.0 KB